Clinical Trial Update: Combination of Atezolizumab With Dendritic Cell Vaccine in Patients With Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

A phased clinical trial evaluating atezolizumab combined with a dendritic cell vaccine in patients with extensive-stage small cell lung cancer (Phase 1/2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• Dendritic cell vaccine

Snippet

Sponsor: Instituto Oncológico Dr Rosell | Conditions: Extensive-stage Small Cell Lung Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING